Men with high-risk prostate cancer who take statin drugs commonly used to lower cholesterol while receiving radiation therapy are less likely to have their cancer return than patients who do not take these medications, according to a new study.
Molecular Biology
Genetics
Genes
Biology
No comments:
Post a Comment